CAPRICOR THERAPEUTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $2.10M, a 10608.89% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $1.47M, a 3071.57% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $6.95K, a 88.93% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $19.58K, a 75.89% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $2.80M, a 814.74% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $305.78K, a 373.33% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $64.60K, a 8.11% decline from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $70.30K, a 149.91% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $2.10M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $1.47M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | $2.80M 10-K · filed 2026-03-17 | |
| 2025-09-30 | $6.95K 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $19.58K 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $46.37K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | $305.78K 10-K · filed 2026-03-17 | |
| 2024-09-30 | $62.81K 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $81.22K 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $64.60K 10-K · filed 2025-03-26 | |
| 2023-06-30 | $57.68K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $3.90K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $70.30K 10-K · filed 2024-03-11 | |
| 2022-09-30 | $1.52K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $15.01K 10-Q · filed 2023-11-14 | |
| 2022-03-31 | $27.46K 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $28.13K 10-K · filed 2023-03-17 | |
| 2021-09-30 | $5.21K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $1.44K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $32.40K 10-K · filed 2022-03-11 | |
| 2020-09-30 | $30.71K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $1.70K 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $2.77K 10-K · filed 2021-03-15 | |
| 2019-09-30 | $225.27K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $2.77K 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $139.14K 10-K · filed 2020-03-27 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | |
| 2018-03-31 | $139.14K 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $6.64K 10-K · filed 2019-03-29 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $13.97K 10-K · filed 2018-03-22 |
| 2016-09-30 | $12.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $13.97K derived: sum of 4 quarters · filed 2017-03-16 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $11.06K derived: sum of 4 quarters · filed 2017-03-16 |
| 2016-03-31 | $986.00 10-Q · filed 2016-05-13 | $11.45K derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $45.46K 10-K · filed 2017-03-16 |
| 2015-09-30 | $10.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $45.69K derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-06-30 | $388.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $37.75K derived: sum of 4 quarters · filed 2016-03-30 |
| 2015-03-31 | $35.00K 10-Q · filed 2015-05-13 | $38.90K derived: sum of 4 quarters · filed 2016-03-30 |
| 2014-12-31 | $233.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.83K 10-K · filed 2016-03-30 |
| 2014-09-30 | $2.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-14 | |
| 2014-06-30 | $1.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | |
| 2014-03-31 | $933.00 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |